Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 35 | 2022 | 692 | 9.300 |
Why?
|
| Quality of Life | 37 | 2022 | 928 | 7.110 |
Why?
|
| Spirituality | 13 | 2018 | 34 | 4.470 |
Why?
|
| Adaptation, Psychological | 20 | 2021 | 136 | 3.690 |
Why?
|
| Psychometrics | 14 | 2020 | 136 | 2.950 |
Why?
|
| Religion and Medicine | 6 | 2016 | 19 | 2.700 |
Why?
|
| Stress, Psychological | 14 | 2021 | 218 | 2.370 |
Why?
|
| Survivors | 12 | 2021 | 159 | 2.270 |
Why?
|
| Self Efficacy | 4 | 2019 | 78 | 2.020 |
Why?
|
| Young Adult | 26 | 2022 | 2613 | 1.490 |
Why?
|
| Health Status | 6 | 2018 | 399 | 1.410 |
Why?
|
| National Institutes of Health (U.S.) | 6 | 2018 | 28 | 1.300 |
Why?
|
| Mental Health | 5 | 2016 | 115 | 1.280 |
Why?
|
| Humans | 64 | 2022 | 32020 | 1.270 |
Why?
|
| Adolescent | 26 | 2022 | 3523 | 1.260 |
Why?
|
| Adult | 37 | 2021 | 9363 | 1.230 |
Why?
|
| Female | 50 | 2021 | 19950 | 1.130 |
Why?
|
| Male | 41 | 2021 | 19193 | 1.030 |
Why?
|
| Personal Satisfaction | 5 | 2018 | 28 | 1.020 |
Why?
|
| Social Support | 7 | 2020 | 179 | 0.960 |
Why?
|
| Patients | 2 | 2016 | 46 | 0.950 |
Why?
|
| Medical Oncology | 2 | 2022 | 84 | 0.940 |
Why?
|
| Middle Aged | 30 | 2020 | 11866 | 0.910 |
Why?
|
| Fatigue | 5 | 2019 | 85 | 0.860 |
Why?
|
| Psychology | 3 | 2019 | 24 | 0.830 |
Why?
|
| Emotions | 4 | 2019 | 56 | 0.750 |
Why?
|
| Chronic Disease | 2 | 2019 | 401 | 0.690 |
Why?
|
| Reproducibility of Results | 9 | 2019 | 765 | 0.690 |
Why?
|
| Colorectal Neoplasms | 3 | 2014 | 216 | 0.670 |
Why?
|
| Cognition | 6 | 2015 | 553 | 0.650 |
Why?
|
| Income | 1 | 2019 | 61 | 0.650 |
Why?
|
| Affective Symptoms | 2 | 2015 | 16 | 0.570 |
Why?
|
| Grief | 1 | 2016 | 1 | 0.560 |
Why?
|
| Attitude to Death | 1 | 2016 | 2 | 0.560 |
Why?
|
| Bereavement | 1 | 2016 | 2 | 0.560 |
Why?
|
| Infertility | 1 | 2016 | 19 | 0.540 |
Why?
|
| Aged | 18 | 2019 | 10338 | 0.530 |
Why?
|
| Religion and Psychology | 3 | 2016 | 7 | 0.520 |
Why?
|
| Caregivers | 3 | 2022 | 113 | 0.510 |
Why?
|
| Guideline Adherence | 1 | 2016 | 119 | 0.510 |
Why?
|
| Biomedical Research | 1 | 2017 | 155 | 0.500 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 97 | 0.500 |
Why?
|
| Anorexia | 1 | 2014 | 4 | 0.500 |
Why?
|
| Cachexia | 1 | 2014 | 7 | 0.490 |
Why?
|
| Continental Population Groups | 1 | 2016 | 237 | 0.490 |
Why?
|
| Health Status Indicators | 1 | 2014 | 73 | 0.480 |
Why?
|
| Aged, 80 and over | 10 | 2019 | 4000 | 0.470 |
Why?
|
| Factor Analysis, Statistical | 6 | 2019 | 76 | 0.460 |
Why?
|
| United States | 11 | 2021 | 3938 | 0.460 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 271 | 0.460 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2014 | 101 | 0.460 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 407 | 0.460 |
Why?
|
| Ethnic Groups | 1 | 2016 | 476 | 0.450 |
Why?
|
| Vomiting | 2 | 2014 | 24 | 0.440 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2014 | 47 | 0.430 |
Why?
|
| Nausea | 2 | 2014 | 53 | 0.430 |
Why?
|
| Nervous System Diseases | 1 | 2013 | 39 | 0.430 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2019 | 507 | 0.430 |
Why?
|
| Survival Rate | 5 | 2019 | 885 | 0.410 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 607 | 0.390 |
Why?
|
| Perception | 1 | 2012 | 98 | 0.380 |
Why?
|
| Depression | 5 | 2019 | 442 | 0.370 |
Why?
|
| Health Personnel | 1 | 2012 | 121 | 0.370 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 409 | 0.360 |
Why?
|
| Ovarian Neoplasms | 3 | 2006 | 94 | 0.340 |
Why?
|
| Mass Screening | 3 | 2006 | 264 | 0.310 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 761 | 0.300 |
Why?
|
| Behavior | 2 | 2015 | 30 | 0.260 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 1529 | 0.260 |
Why?
|
| Behavioral Medicine | 2 | 2016 | 5 | 0.250 |
Why?
|
| Attitude | 1 | 2005 | 40 | 0.250 |
Why?
|
| Socioeconomic Factors | 3 | 2013 | 420 | 0.240 |
Why?
|
| Cancer Care Facilities | 2 | 2017 | 10 | 0.230 |
Why?
|
| Interpersonal Relations | 2 | 2015 | 57 | 0.230 |
Why?
|
| Registries | 2 | 2017 | 298 | 0.210 |
Why?
|
| Prevalence | 3 | 2015 | 981 | 0.210 |
Why?
|
| Resilience, Psychological | 1 | 2021 | 16 | 0.200 |
Why?
|
| Cohort Studies | 4 | 2014 | 1831 | 0.200 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 29 | 0.200 |
Why?
|
| Religion | 3 | 2016 | 32 | 0.190 |
Why?
|
| Patient-Centered Care | 1 | 2022 | 75 | 0.190 |
Why?
|
| Health Expenditures | 1 | 2021 | 66 | 0.190 |
Why?
|
| Program Evaluation | 1 | 2021 | 186 | 0.190 |
Why?
|
| Motivation | 1 | 2021 | 111 | 0.180 |
Why?
|
| Meditation | 1 | 2020 | 22 | 0.180 |
Why?
|
| Social Change | 1 | 2019 | 3 | 0.170 |
Why?
|
| Psychotherapy | 1 | 2019 | 19 | 0.170 |
Why?
|
| Calibration | 1 | 2019 | 27 | 0.170 |
Why?
|
| Treatment Outcome | 3 | 2016 | 3317 | 0.170 |
Why?
|
| Focus Groups | 1 | 2019 | 113 | 0.160 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 100 | 0.160 |
Why?
|
| Communication | 1 | 2020 | 140 | 0.160 |
Why?
|
| Qualitative Research | 1 | 2019 | 166 | 0.160 |
Why?
|
| Comprehension | 1 | 2018 | 19 | 0.160 |
Why?
|
| Databases, Factual | 2 | 2017 | 355 | 0.150 |
Why?
|
| Electronic Health Records | 2 | 2017 | 162 | 0.150 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2017 | 19 | 0.140 |
Why?
|
| Chicago | 1 | 2016 | 10 | 0.140 |
Why?
|
| Health Behavior | 3 | 2009 | 231 | 0.140 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 58 | 0.140 |
Why?
|
| Hospitals, Pediatric | 1 | 2017 | 47 | 0.140 |
Why?
|
| Dementia | 1 | 2019 | 252 | 0.140 |
Why?
|
| Follow-Up Studies | 3 | 2019 | 2280 | 0.140 |
Why?
|
| Affect | 2 | 2013 | 69 | 0.130 |
Why?
|
| Fertility | 1 | 2016 | 31 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 36 | 0.130 |
Why?
|
| Spiritual Therapies | 1 | 2015 | 2 | 0.130 |
Why?
|
| Indoles | 1 | 2016 | 56 | 0.130 |
Why?
|
| Documentation | 1 | 2016 | 46 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2016 | 67 | 0.130 |
Why?
|
| Students | 2 | 2009 | 172 | 0.130 |
Why?
|
| Pyrroles | 1 | 2016 | 55 | 0.130 |
Why?
|
| Pyrimidines | 1 | 2016 | 65 | 0.130 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2015 | 34 | 0.130 |
Why?
|
| Appetite Stimulants | 1 | 2014 | 1 | 0.120 |
Why?
|
| Receptors, Ghrelin | 1 | 2014 | 2 | 0.120 |
Why?
|
| Prognosis | 1 | 2019 | 1505 | 0.120 |
Why?
|
| Hydrazines | 1 | 2014 | 4 | 0.120 |
Why?
|
| Palliative Care | 1 | 2015 | 52 | 0.120 |
Why?
|
| Placebos | 1 | 2014 | 63 | 0.120 |
Why?
|
| Appetite | 1 | 2014 | 22 | 0.120 |
Why?
|
| Whole-Body Irradiation | 1 | 2015 | 50 | 0.120 |
Why?
|
| Oligopeptides | 1 | 2014 | 45 | 0.120 |
Why?
|
| Child | 4 | 2015 | 2440 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 168 | 0.120 |
Why?
|
| Odds Ratio | 1 | 2016 | 474 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 899 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 114 | 0.120 |
Why?
|
| Patient Care Planning | 1 | 2015 | 59 | 0.120 |
Why?
|
| Primary Health Care | 1 | 2017 | 227 | 0.120 |
Why?
|
| Hand Strength | 1 | 2014 | 101 | 0.120 |
Why?
|
| Sex Factors | 1 | 2016 | 663 | 0.120 |
Why?
|
| Sickness Impact Profile | 2 | 2011 | 35 | 0.110 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 200 | 0.110 |
Why?
|
| Employment | 1 | 2013 | 49 | 0.110 |
Why?
|
| Mood Disorders | 1 | 2012 | 21 | 0.110 |
Why?
|
| Regression Analysis | 2 | 2014 | 294 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2015 | 1269 | 0.110 |
Why?
|
| Educational Status | 1 | 2013 | 179 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2014 | 2281 | 0.100 |
Why?
|
| Antiemetics | 1 | 2012 | 6 | 0.100 |
Why?
|
| Social Desirability | 2 | 2009 | 12 | 0.100 |
Why?
|
| Pediatrics | 1 | 2013 | 157 | 0.100 |
Why?
|
| Psychotherapy, Brief | 1 | 2011 | 5 | 0.100 |
Why?
|
| Self Concept | 1 | 2011 | 42 | 0.100 |
Why?
|
| Social Isolation | 1 | 2011 | 43 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2011 | 70 | 0.090 |
Why?
|
| Weight Loss | 1 | 2014 | 480 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2020 | 544 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 182 | 0.090 |
Why?
|
| Kentucky | 1 | 2009 | 15 | 0.080 |
Why?
|
| Retrospective Studies | 1 | 2017 | 3523 | 0.080 |
Why?
|
| Universities | 1 | 2009 | 145 | 0.080 |
Why?
|
| Feasibility Studies | 2 | 2020 | 292 | 0.070 |
Why?
|
| Anxiety | 2 | 2021 | 188 | 0.070 |
Why?
|
| Psychological Theory | 1 | 2007 | 6 | 0.070 |
Why?
|
| Parents | 2 | 2021 | 147 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2006 | 379 | 0.060 |
Why?
|
| Information Systems | 2 | 2015 | 10 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2018 | 771 | 0.060 |
Why?
|
| Endosonography | 1 | 2004 | 56 | 0.060 |
Why?
|
| Vagina | 1 | 2004 | 57 | 0.060 |
Why?
|
| Substance-Related Disorders | 2 | 2016 | 127 | 0.050 |
Why?
|
| Parent-Child Relations | 1 | 2021 | 46 | 0.050 |
Why?
|
| Age Factors | 2 | 2015 | 1194 | 0.040 |
Why?
|
| Waiting Lists | 1 | 2020 | 34 | 0.040 |
Why?
|
| Risk Factors | 2 | 2004 | 3869 | 0.040 |
Why?
|
| Education, Distance | 1 | 2019 | 19 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 126 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 221 | 0.030 |
Why?
|
| Exercise | 1 | 2021 | 672 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2017 | 141 | 0.030 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2015 | 54 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2015 | 10 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2015 | 25 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 21 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 15 | 0.030 |
Why?
|
| American Cancer Society | 1 | 2015 | 3 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 319 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2015 | 78 | 0.030 |
Why?
|
| Internet | 1 | 2016 | 195 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 48 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 103 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 76 | 0.030 |
Why?
|
| Ovariectomy | 1 | 2015 | 149 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 247 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 124 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 99 | 0.030 |
Why?
|
| SEER Program | 1 | 2014 | 35 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 312 | 0.030 |
Why?
|
| Happiness | 1 | 2013 | 3 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2015 | 397 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 323 | 0.030 |
Why?
|
| Macrophages | 1 | 2015 | 192 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2015 | 508 | 0.030 |
Why?
|
| Pain | 1 | 2014 | 287 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1200 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 263 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 464 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 110 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2009 | 107 | 0.020 |
Why?
|
| CA-125 Antigen | 1 | 2006 | 7 | 0.020 |
Why?
|
| Ovary | 1 | 2006 | 58 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 77 | 0.020 |
Why?
|
| Probability | 1 | 2005 | 158 | 0.020 |
Why?
|
| Mastectomy | 1 | 2005 | 65 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2005 | 83 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 207 | 0.020 |
Why?
|
| Elder Abuse | 1 | 2004 | 1 | 0.020 |
Why?
|
| Defense Mechanisms | 1 | 2004 | 4 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2005 | 192 | 0.020 |
Why?
|
| Sick Role | 1 | 2004 | 7 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2004 | 62 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2006 | 165 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 456 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 7466 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 878 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 1435 | 0.010 |
Why?
|